One of the integral molecules of the IFN receptor signaling is STAT3 (8) and a SNP in STAT3 (i.e., rs4796793) has been reported to be associated with response to IFNα therapy in renal cell carcinoma patients (7). Here, STAT3 is linked to hereditary clear cell renal cell carcinoma.